Literature DB >> 15710351

Inhibition of tristetraprolin expression by dexamethasone in activated macrophages.

Ulla Jalonen1, Aleksi Lahti, Riku Korhonen, Hannu Kankaanranta, Eeva Moilanen.   

Abstract

Tristetraprolin (TTP) is a factor that regulates mRNA stability and the expression of certain inflammatory genes. In the present study, we found that TTP expression was increased in macrophages exposed to bacterial lipopolysaccharide (LPS). Dexamethasone and dissociated steroid RU24858 inhibited LPS-induced TTP protein and mRNA expression and the inhibitory effect was reversed by a glucocorticoid receptor antagonist mifepristone. Histone deacetylase inhibitors trichostatin A (TSA) and apicidin reduced the inhibitory effect of dexamethasone and RU24858 on TTP expression, but the glucocorticoids did not alter TTP mRNA half-life. These results suggest that anti-inflammatory steroids reduce TTP expression in activated macrophages by a glucocorticoid response element (GRE)-independent mechanism, possibly through histone deacetylation and transcriptional silencing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710351     DOI: 10.1016/j.bcp.2004.11.027

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

Review 1.  Glucocorticoid and cytokine crosstalk: Feedback, feedforward, and co-regulatory interactions determine repression or resistance.

Authors:  Robert Newton; Suharsh Shah; Mohammed O Altonsy; Antony N Gerber
Journal:  J Biol Chem       Date:  2017-03-10       Impact factor: 5.157

2.  Milk fat globule-EGF factor 8 mediates the enhancement of apoptotic cell clearance by glucocorticoids.

Authors:  K Lauber; H Keppeler; L E Munoz; U Koppe; K Schröder; H Yamaguchi; G Krönke; S Uderhardt; S Wesselborg; C Belka; S Nagata; M Herrmann
Journal:  Cell Death Differ       Date:  2013-07-05       Impact factor: 15.828

3.  Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory signaling.

Authors:  Kathleen Smoak; John A Cidlowski
Journal:  Mol Cell Biol       Date:  2006-09-18       Impact factor: 4.272

Review 4.  How corticosteroids control inflammation: Quintiles Prize Lecture 2005.

Authors:  Peter J Barnes
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

5.  Transcriptional regulation of tristetraprolin by NF-κB signaling in LPS-stimulated macrophages.

Authors:  Yu-Ling Chen; Yu-Wun Jiang; Yu-Lun Su; Sheng-Chung Lee; Mau-Sun Chang; Ching-Jin Chang
Journal:  Mol Biol Rep       Date:  2012-12-01       Impact factor: 2.316

6.  Role of the RNA-binding protein tristetraprolin in glucocorticoid-mediated gene regulation.

Authors:  Faoud T Ishmael; Xi Fang; Maria Rosaria Galdiero; Ulus Atasoy; William F C Rigby; Myriam Gorospe; Chris Cheadle; Cristiana Stellato
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

7.  Negative Feed-forward Control of Tumor Necrosis Factor (TNF) by Tristetraprolin (ZFP36) Is Limited by the Mitogen-activated Protein Kinase Phosphatase, Dual-specificity Phosphatase 1 (DUSP1): IMPLICATIONS FOR REGULATION BY GLUCOCORTICOIDS.

Authors:  Suharsh Shah; Mahmoud M Mostafa; Andrew McWhae; Suzanne L Traves; Robert Newton
Journal:  J Biol Chem       Date:  2015-11-06       Impact factor: 5.157

8.  The glucocorticoid RU24858 does not distinguish between transrepression and transactivation in primary human eosinophils.

Authors:  Mirkka Janka-Junttila; Eeva Moilanen; Hannele Hasala; Xianzhi Zhang; Ian Adcock; Hannu Kankaanranta
Journal:  J Inflamm (Lond)       Date:  2006-07-12       Impact factor: 4.981

9.  Heterogeneity of glucocorticoid resistance in patients with bronchial asthma.

Authors:  Yasuhiro Matsumura
Journal:  Int J Biomed Sci       Date:  2010-09

10.  Down-regulation of tristetraprolin expression results in enhanced IL-12 and MIP-2 production and reduced MIP-3alpha synthesis in activated macrophages.

Authors:  Ulla Jalonen; Riina Nieminen; Katriina Vuolteenaho; Hannu Kankaanranta; Eeva Moilanen
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.